WO2001075063A3 - Haplotypes du gene chrnb3 - Google Patents

Haplotypes du gene chrnb3 Download PDF

Info

Publication number
WO2001075063A3
WO2001075063A3 PCT/US2001/010277 US0110277W WO0175063A3 WO 2001075063 A3 WO2001075063 A3 WO 2001075063A3 US 0110277 W US0110277 W US 0110277W WO 0175063 A3 WO0175063 A3 WO 0175063A3
Authority
WO
WIPO (PCT)
Prior art keywords
chrnb3
gene
haplotypes
disclosed
polymorphisms
Prior art date
Application number
PCT/US2001/010277
Other languages
English (en)
Other versions
WO2001075063A2 (fr
Inventor
Anne Chew
Julie Y Choi
Beena Koshy
J Claiborne Stephens
Original Assignee
Genaissance Pharmaceuticals
Anne Chew
Julie Y Choi
Beena Koshy
J Claiborne Stephens
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genaissance Pharmaceuticals, Anne Chew, Julie Y Choi, Beena Koshy, J Claiborne Stephens filed Critical Genaissance Pharmaceuticals
Priority to AU2001249650A priority Critical patent/AU2001249650A1/en
Publication of WO2001075063A2 publication Critical patent/WO2001075063A2/fr
Publication of WO2001075063A3 publication Critical patent/WO2001075063A3/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/20Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Theoretical Computer Science (AREA)
  • Medical Informatics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Evolutionary Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

L'invention concerne des polymorphismes à nucléotide unique dans le gène du récepteur cholinergique, nicotinique, bêta polypeptide 3 humain (CHRNB3), ainsi que divers génotypes, haplotypes et paires d'haplotypes pour le gène CHRNB3 existant dans la population. L'invention concerne en outre des compositions et des procédés permettant l'haplotypage et/ou le génotypage du gène CHRNB3 chez un individu. L'invention concerne enfin des polynucléotides renfermant un ou plusieurs polymorphismes de CHRNB3.
PCT/US2001/010277 2000-04-03 2001-03-30 Haplotypes du gene chrnb3 WO2001075063A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001249650A AU2001249650A1 (en) 2000-04-03 2001-03-30 Haplotypes of the chrnb3 gene

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19416200P 2000-04-03 2000-04-03
US60/194,162 2000-04-03

Publications (2)

Publication Number Publication Date
WO2001075063A2 WO2001075063A2 (fr) 2001-10-11
WO2001075063A3 true WO2001075063A3 (fr) 2002-02-07

Family

ID=22716520

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/010277 WO2001075063A2 (fr) 2000-04-03 2001-03-30 Haplotypes du gene chrnb3

Country Status (2)

Country Link
AU (1) AU2001249650A1 (fr)
WO (1) WO2001075063A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002324842C9 (en) 2001-08-31 2008-07-10 Agensys, Inc. 205P1B5 in treatment and detection of cancer

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996041876A1 (fr) * 1995-06-07 1996-12-27 Sibia Neurosciences, Inc. Compositions destinees au recepteur neuronal humain de l'acetylcholine nicotinique et leurs procedes d'utilisation

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996041876A1 (fr) * 1995-06-07 1996-12-27 Sibia Neurosciences, Inc. Compositions destinees au recepteur neuronal humain de l'acetylcholine nicotinique et leurs procedes d'utilisation

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
DATABASE GENBANK [online] NATIONAL CENTER FOR BIOTECH. INFORMATION, NLM, NIH (BETHEDA, MD, USA); 30 May 1999 (1999-05-30), XP002949421, accession no. NCBI Database accession no. AF140765 *
DATABASE GENBANK [online] NATIONAL CENTER FOR BIOTECH. INFORMATION, NLM, NIH (BETHESDA, MD, USA); 30 May 1999 (1999-05-30), XP002949415, accession no. NCBI Database accession no. AH007742 *
DATABASE GENBANK [online] NATIONAL CENTER FOR BIOTECH. INFORMATION, NLM, NIH (BETHESDA, MD, USA); 30 May 1999 (1999-05-30), XP002949416, accession no. NCBI Database accession no. AF140760 *
DATABASE GENBANK [online] NATIONAL CENTER FOR BIOTECH. INFORMATION, NLM, NIH (BETHESDA, MD, USA); 30 May 1999 (1999-05-30), XP002949417, accession no. NCBI Database accession no. AF140761 *
DATABASE GENBANK [online] NATIONAL CENTER FOR BIOTECH. INFORMATION, NLM, NIH (BETHESDA, MD, USA); 30 May 1999 (1999-05-30), XP002949418, accession no. NCBI Database accession no. AF140762 *
DATABASE GENBANK [online] NATIONAL CENTER FOR BIOTECH. INFORMATION, NLM, NIH (BETHESDA, MD, USA); 30 May 1999 (1999-05-30), XP002949419, accession no. NCBI Database accession no. AF140763 *
DATABASE GENBANK [online] NATIONAL CENTER FOR BIOTECH. INFORMATION, NLM, NIH (BETHESDA, MD, USA); 30 May 1999 (1999-05-30), XP002949420, accession no. NCBI Database accession no. AF140764 *

Also Published As

Publication number Publication date
AU2001249650A1 (en) 2001-10-15
WO2001075063A2 (fr) 2001-10-11

Similar Documents

Publication Publication Date Title
WO2001079229A3 (fr) Haplotypes du gene cxcr4
WO2001079234A3 (fr) Haplotypes du gene apoe
WO2001079230A3 (fr) Haplotypes du gene ugt1a1
WO2001077124A3 (fr) Haplotypes du gene apoa4
WO2001090123A3 (fr) Haplotypes du gene agtrl1
WO2001075063A3 (fr) Haplotypes du gene chrnb3
WO2001077363A3 (fr) Haplotypes du gene impdh2
WO2002026764A3 (fr) Haplotypes du gene ccr6
WO2001079228A3 (fr) Haplotypes du gene f12
WO2001074833A3 (fr) Haplotypes du gene chrnb2
WO2001079221A3 (fr) Haplotypes du gene il8rb
WO2001079224A3 (fr) Haplotypes du gene cyp8b1
WO2001077129A3 (fr) Haplotypes du gene apoc1
WO2001077125A3 (fr) Haplotypes du gene ccr5
WO2001079219A3 (fr) Haplotypes du gene ache
WO2001079237A3 (fr) Haplotypes du gene galr1
WO2001072966A3 (fr) Haplotypes du gene pltp
WO2001079218A3 (fr) Haplotypes du gene calm1
WO2002026766A3 (fr) Haplotypes du gene sstr4
WO2001079238A3 (fr) Haplotypes du gene mmp3
WO2002002580A3 (fr) Haplotypes du gene etfb
WO2002016399A3 (fr) Haplotypes du gene tacr1
WO2001079222A3 (fr) Haplotypes du gene mc4r
WO2001083499A3 (fr) Haplotypes du gene de l'il8
WO2002032924A3 (fr) Haplotypes du gene chrm5

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WPC Withdrawal of priority claims after completion of the technical preparations for international publication

Ref country code: WO

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP